Company ProfilePremium

Nanoveu Limited

Company Profile Analysis

Ticker: NVU.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Nanoveu Limited - Company showcase

Year Founded & Workforce

2001

24 Employees

Nanoveu Limited logo

Nanoveu Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Nanoveu Limited Overview

Nanoveu began as a nanotechnology films company. Its products were EyeFly3D glasses-free 3D screen films and Nanoshield copper-ion antimicrobial films. It is now a fabless edge-AI semiconductor developer, and its consumer-optics and coatings businesses are secondary. The change came with the March 2025 acquisition of Embedded A.I. Systems Pte Ltd (EMASS), which was paid for entirely in shares. EMASS is a spinout from Singapore's Nanyang Technological University. Its ECS-DoT system-on-chip runs AI inference at sub-milliwatt power. The company currently offers the chip at 22nm and received first 16nm engineering samples from TSMC in September 2026. In July 2026 Nanoveu bought Spinoff Robotics, a spinout of the Singapore University of Technology and Design. This gave it in-house drone airframes, and the company now describes its offer as a full "silicon-to-airframe" drone stack. Commercial traction is still minimal: FY2025 revenue was A$0.30M and H1 FY2026 revenue was A$0.007M. The company depends on equity raisings. Investors are therefore valuing technology optionality on a roughly A$60M market capitalisation rather than any earnings base.


Company's own description (FY2025 Annual Report, paraphrased)

The company describes its principal activity as developing and commercialising advanced technologies in three fields: semiconductor systems, visualisation software and materials science. It runs these through three operating divisions:

EMASS (Semiconductor Technology): EMASS designs systems-on-chip (SoCs) for ultra-low-power, AI-driven processing. Target uses are smart devices, IoT and 3D content transformation, sold into edge-computing markets.

EyeFly3D™ (Nanotechnology and Software): This is a proprietary display enhancement that gives glasses-free 3D on mobile and consumer displays. It combines nanostructured optical films with AI-driven 2D-to-3D software and targets mobile content, entertainment, e-commerce and gaming.

Nanoshield™ (Materials Science and Coatings): This is a protective coating for photovoltaic panels and, in the H1 FY2026 description, also concentrated solar power (CSP). It is meant to reduce biofilm, algae and environmental degradation.

Since July 2026, a Drone Division built from Spinoff Robotics sits alongside EMASS. Its job is to commercialise ECS-DoT in unmanned aerial systems.

Business model and revenue model

Revenue streamSegmentModelStatus (as of Oct 2026)
ECS-DoT chip sales (22nm, later 16nm)SemiconductorProduct sales through OEM design-ins and distributors (Arrow collaboration; a China distributor appointed in Q2 2026)No semiconductor revenue recognised in FY2025 or H1 FY2026
Evaluation boards, reference designs, SDKsSemiconductorProduct sales and design-in enablementNo disclosed revenue
Licensing and engineering servicesSemiconductorIP licensing and non-recurring engineering (NRE), per the segment definitionNo disclosed revenue
Drone platforms (ALICE tethered drone, METRON photogrammetry)Drone (within Semiconductor/new)Hardware sales plus ECS-DoT-enabled solutions to drone OEMsAcquired July 2026; no revenue disclosed
EyeFly3D films (screen protectors)EyeFly3DHardware sales through OEMs and distributors, via the 51%-owned Fullveu JVA$285,164 in FY2025; A$6,954 in H1 FY2026; US$300K India pilot purchase order (Aug 2026)
EyeFly3D software / white-label SaaSEyeFly3DPlanned subscription and licensing modelStrategic intent only
Nanoshield coatings / licencesNanoshieldProduct sales; exclusive CSP licence with Diamon-Fusion InternationalA$12,418 in FY2025; nil in H1 FY2026

Revenue mix (FY2025, audited): all revenue was recorded as "sale of goods" (A$297,582). EyeFly3D supplied 95.8% and Nanoshield 4.2%. There was no subscription, licensing or service revenue.

Value-chain position

EMASS is a fabless chip designer. It owns the architecture (RISC-V core, deep-learning accelerators and the power-management fabric), the IP, the software toolchain and the reference designs. Wafer fabrication is outsourced to TSMC. Packaging, test and distribution are handled by third parties, with Arrow Electronics collaborating on boards and developer tools. With Spinoff Robotics, Nanoveu now also does system-level airframe and flight-control engineering. The company calls the result a "silicon-to-airframe" or "Atoms-to-Apps" stack. EyeFly3D buys films through its Hong Kong JV with Shenzhen Fullsand Printing & Packaging. Under the JV agreements, product is supplied at an 8% premium to manufacturing cost.

Customer types and end-markets

Semiconductor: OEMs and integrators in consumer wearables, hearables and hearing aids, smart glasses, smart home and security, asset tracking and logistics, industrial monitoring and predictive maintenance, and drones/robotics including defence (H1 FY2026 Interim Report).

EyeFly3D: B2B partners with content (OTT platforms, distributors). Examples are One Immersive Inc. in India and Rahum Nano Tech in South Korea.

Nanoshield: solar farm and CSP operators and industrial PV owners. Ageing panels (3–5 years old) are the stated initial target because OEM warranties restrict coatings on new panels.

Independent characterisation

Nanoveu is a pre-revenue deep-tech holding company, listed on the ASX microcap board and funded by equity. Its economic value sits almost entirely in the EMASS intangible, carried at A$10.49M. That figure is the share-based acquisition cost, not an independent valuation. The legacy divisions have produced small, irregular revenue for eight years. They now serve mainly as a source of near-term cash and as secondary applications for EMASS: EMASS's Class A performance rights are tied to running the 2D-to-3D model on ECS-DoT. The investment case rests on three questions. Will ECS-DoT win production design-ins? Will that happen before the company needs much more dilutive capital? And can a roughly 1.09bn-share, 1.49bn fully diluted company produce per-share value from a chip startup's economics?

Strategy

Stated strategy (FY2025 Annual Report, paraphrased themes)

Commercialise, expand markets, integrate technology: The focus is building commercial partnerships that embed EMASS technology into real-world edge-AI products and drive industry adoption.

EyeFly3D: grow hardware sales while developing a white-labelled B2B SaaS platform that enables subscription and licensing revenue.

Nanoshield Solar: grow sales and expand markets on the back of field trials.

Overall aim: scale the commercial footprint, strengthen alliances and achieve sustained revenue growth.

Semiconductor near-term priorities: validate production silicon, continue OEM engagement, and progress to early commercial design-ins.

Strategic initiatives (last 24 months)

InitiativeDateDescriptionStatus
Pivot to semiconductors (EMASS)Oct 2024–Mar 2025Acquired an NTU-origin fabless edge-AI SoC companyCompleted
Semiconductor leadership build-outJan–Apr 2025Goranson appointed CEO; US team expandedCompleted
Two-node silicon roadmap2025–202622nm commercial; 16nm taped out in Jan 2026 with samples in Sep 2026; smaller nodes under evaluationCharacterisation under way
22nm full-mask tape-outH2 2026 (expected)Move from earlier manufacturing runs to a production mask setPending
Drone verticalOct 2025–Jul 2026Simulations, live trials, NTU swarm IP licence, Spinoff Robotics acquisitionExecuting
Ecosystem partnerships2025–2026Arrow, Semtech, Bosch Sensortec, STMicro sensing (reference design), Weebit Nano (ReRAM)Ongoing
Channel build2025–2026US sales and representation network; China distributor (Q2 2026)Ongoing
EyeFly3D B2B refocus2024–2026Fullveu JV, Korea and India OEM deals, content-partner modelPilot stage
Nanoshield CSPH1 2026Exclusive Diamon-Fusion CSP licenceEarly stage
Capital programmeJan 2026A$7.5M placement at A$0.088 with 1-for-2 options at A$0.15Completed
US investor access2024–2025OTCQB quotation (NNVUF)Completed

ESG / sustainability commitments

No formal emissions targets or ESG programmes are disclosed. The Annual Report states the company is not subject to significant environmental regulation.

Cost programmes

No formal cost-reduction targets are disclosed. The Malaysian entity was dissolved.

Medium-term financial targets / guidance

Not publicly disclosed. The company gives no revenue or earnings guidance. The incentive structures do signal management's own milestones:

  • EMASS Class C performance rights vest on A$1M of cumulative contracted revenue over 12 months, with an expiry of 18 Mar 2030.

  • Fullveu-linked performance rights target US$2.5M of Fullveu revenue for FY2026 (tranche B, 6M rights) and a further 10M rights expiring 31 Dec 2027.

  • Market-based rights vest at 20-day VWAPs of A$0.10, A$0.15 and A$0.20.

  • A legacy hurdle of A$15M consolidated revenue for FY2025 (tranche C) was missed and lapsed.

Products & Services

Semiconductor (EMASS)

ProductDescription and key capabilitiesTarget customerLaunch / versionPricing
ECS-DoT 22nm SoCFabless edge-AI SoC with a RISC-V core, dual deep-learning accelerators, scalable compute-to-memory interconnect and an always-on design. Real-time inference at sub-mW to low-mW power. Demonstrated running keyword detection and voice recognition at the same time at about 400–500 µW average power with roughly 4ms latency (Jun 2026).Wearables, hearables, smart home, asset tracking, industrial IoT, dronesCommercially available; full-mask 22nm tape-out expected to start in H2 2026—
ECS-DoT 16nm SoCTSMC 16nm FinFET. Keeps the 22nm architecture and adds an integrated Bluetooth Low Energy radio subsystem, expanded on-chip SRAM, a dedicated object-detection accelerator (non-maximum suppression stage covered by exclusively licensed US Patent 12,651,452 B2), a hardware FP16/FP32 floating-point unit, and a fine-grained adaptive power-management fabric without DVFS. Software and toolchain compatible with the 22nm chip.Customers needing vision plus audio plus sensor fusion with integrated wirelessGDS sign-off Dec 2025; tape-out Jan 2026; engineering samples received ~Sep 2026; characterisation under way—
Evaluation boards and compact AI prototyping boardDevelopment hardware for ECS-DoT. A compact board was unveiled in 2024–25.OEM engineers2024–2026—
SDK / AI toolchainModel compression and deployment tools ("Atoms-to-Apps" method)OEM developersOngoing—
Reference design: hearables keyword spottingAlways-on bone-conduction keyword spotting combining STMicroelectronics inertial sensing with ECS-DoT. Microphone-free keyword spotting below 1mW.Hearables and hearing aidsMar 2026; Jun 2026—
Reference design: asset tracking (with Bosch Sensortec)Five Bosch MEMS sensors (motion, environmental, pressure, magnetic, gas) with ECS-DoT for context-aware tracking, including GPS-denied environmentsLogistics, cold chain, industrial IoTJul 2026—
Reference design: LoRa intelligent sensing (with Semtech)ECS-DoT combined with Semtech LoRa transceivers for long-range, battery-efficient predictive maintenance and acoustic event detectionIndustrial IoTQ4 2025—
ECS-DoT drone flight-control AIClosed-loop AI flight optimisation. Simulation showed about 60% average and up to 85% peak endurance gains. Live trials: 27.2% average cruise-efficiency gain (Jun 2026) and 48.5% average at 7 m/s (Jul 2026, Phase 2), using under 10mW total system power, with no battery or airframe changes.Drone OEMs, defence, inspectionLive trials 2026—
Fall-detection demoUltra-low-power fall detection on ECS chipHealth wearables2024–25—

Drone Division (Spinoff Robotics, acquired July 2026)

ProductDescriptionTarget customerStatus
ALICEProprietary tethered drone platform for persistent station-keeping, such as surveillance and monitoringDefence, security, infrastructureCompany describes it as in active commercial deployment; no revenue disclosed
METRONDrone platform for sub-millimetre photogrammetryInfrastructure inspectionCommercially validated per company; no revenue disclosed
Planned capabilitiesGPS-free navigation, counter-drone detection, AI flight optimisation (using the NTU swarm IP licence)Drone OEMs, defenceDevelopment roadmap

EyeFly3D

ProductDescriptionTarget customerStatus / pricing
EyeFly3D filmsPlastic (PET) or tempered-glass screen protectors engineered with around half a million nano-lenses for glasses-free 3D. The 3D effect has been toned down to address eye-strain complaints.Smartphone users via OEMs and distributorsKorea (Rahum, 2024); India (One Immersive pilot purchase order of US$300K, Aug 2026). Price n.d.
EyeFly3D AI 2D-to-3D software / appMonocular depth estimation converts 2D content to 3D in real timeOTT and content partnersPlanned white-label B2B SaaS and licensing
EyeFyx (legacy, development)Vision-correction display concept using hardware and softwareConsumersLegacy development; current status not disclosed

Nanoshield

ProductDescriptionStatus
Nanoshield SolarAnti-fouling, anti-biofilm coating for PV panels; field trials in hot, arid regions (EMEA referenced)Trials; FY2025 revenue A$12.4K
Nanoshield CSP (Diamon-Fusion licence)Exclusive global licence to use Diamon-Fusion® nanocoating in concentrated solar powerSigned in H1 FY2026; aims to improve asset performance and reduce water and maintenance
Nanoshield antiviral / antimicrobial filmsCopper-ion film for screens, cases and commercial surfacesLegacy COVID-era product
Nanoshield MarineAnti-biofouling for submerged surfacesLegacy; status not disclosed
Customskins (legacy)Vending machines that apply screen coversLegacy; status not disclosed

Financial Narrative

Income statement — 5-year summary

Sources: FY2024–FY2025 revenue is from the audited FY2025 Annual Report. Net loss and EPS for all years are from the FY2025 Remuneration Report's five-year table. Diluted EPS equals basic EPS because options are anti-dilutive.

Revenue CAGR FY2021–FY2025 (calculated): -21.4% a year. The pattern is volatile rather than a steady decline: revenue peaked in the COVID-era Nanoshield period, was near zero in FY2024, and partly recovered in FY2025 on EyeFly3D JV shipments.

Income statement — detailed (audited)

Notes: FY2024 cost of sales was a credit of A$3.7K, which produced a gross profit above revenue. This is an accounting anomaly. EBITDA is calculated as operating loss plus D&A from Note 6 (A$173.1K). The cash-flow reconciliation shows only A$32.6K of non-cash D&A, which is an internal inconsistency in the filing. FY2025 administration expense includes a one-off A$692.6K donation to a university to support research collaboration, A$755.2K of consulting fees, and A$1.63M of director and employee costs.

Margins (calculated from audited figures)

Margins are not economically meaningful at this revenue level. The FY2025 negative gross margin (cost of sales of A$929.7K on revenue of A$297.6K) suggests inventory write-downs, under-absorbed production cost or below-cost pilot pricing at EyeFly3D. The filing does not break this out.

Balance sheet

Notes: FY2024 cash of A$498.3K included A$400K of restricted cash. The FY2025 going-concern note states net current assets of A$1,284,566. That differs from the A$1,356,457 calculated from the balance sheet, a discrepancy within the filing. FY2023 closing total equity was -A$109.4K (from the statement of changes in equity). Other FY2021–FY2023 balance-sheet lines are not publicly disclosed in the sources reviewed.

Latest balance sheet (30 Jun 2026, reviewed): total assets A$17.66M; cash A$5.14M; intangibles A$10.50M; loan receivable A$451.8K; contract liabilities A$544.4K; interest-free loan A$237.7K; lease liabilities A$477.6K; total equity A$15.52M (owners A$15.87M, NCI -A$0.35M); working capital A$4.68M.

Cash flow

H1 FY2026 (reviewed): operating cash flow -A$3.93M (H1 FY2025: -A$1.99M); capex -A$13K; net financing +A$7.28M, of which the placement was A$7.03M and option exercises A$0.19M. Customer receipts were A$392K, much higher than recognised revenue of A$7K. This reflects deposits, including about US$165K from One Immersive, held as contract liabilities.

Ratios (calculated)

ROIC, net debt/EBITDA, interest coverage and cash conversion cycle are not meaningful. Operating earnings are negative, the company holds net cash, finance costs are trivial (A$13.7K) and there is no material inventory or receivables cycle. FY2024 ROE and ROA cannot be meaningfully calculated because the average FY2023–FY2024 equity base was about A$0.11M, and FY2023 total assets are not disclosed.

Commentary — trends, inflections and drivers

  1. The FY2025 inflection is in costs, not revenue. Operating cash burn more than tripled, from A$1.84M to A$5.85M. In H1 FY2026 the run-rate reached about A$7.9M a year (A$3.93M per half). This is the cost of running an international chip design team across Singapore, Cairo and the US, a TSMC tape-out and drone programs.

  2. The balance sheet was rebuilt with equity. Equity went from A$0.34M to A$12.09M in FY2025, almost entirely from the share-funded EMASS acquisition (A$10.47M) and A$7.47M of net cash raised. The A$10.5M intangible is "not yet available for use". It is therefore not amortised and is tested for impairment each year, using fair value less costs of disposal based on the original arm's-length deal price.

  3. Funding is short. Cash of A$5.14M at 30 June 2026, at the H1 burn rate of about A$0.66M a month, gives roughly 7–8 months of runway to around Q1 2027 before new inflows. Possible inflows: the A$433.5K India purchase order balance; in-the-money options (93.4M unlisted at A$0.05 expiring 31 Dec 2026, about A$4.7M if exercised; 68.8M listed at A$0.045 expiring May 2027, about A$3.1M); and repayment of the Hongtai Sheng loan, which matured 31 July 2026 (A$452K at book). The directors' going-concern conclusion relies on existing cash plus forecast product receipts.

  4. Share-based payment intensity is high. Share-based payments were A$1.42M in FY2025, equal to 4.8 times revenue. Director share-based payments made up 59% of key management remuneration.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment revenue (AUD K)

Segment revenue (AUD K)FY2024FY2025

Semiconductor

00

EyeFly 3D

6.9285.2

Nanoshield

012.4

Corporate

00

Total

6.9297.6

Segment profit or loss (AUD K)

Segment profit or loss (AUD K)FY2024FY2025

Semiconductor

0-2,501.0

EyeFly 3D

-1,039.6-1,149.3

Nanoshield

-12.0-104.6

Corporate

-1,794.8-3,847.3

Total

-2,846.4-7,601.2

Segment Overview

SegmentRevenue share (%)YoY revenue growthSegment margin (loss/revenue)

Semiconductor

0.0—

n.m. (no revenue)

EyeFly 3D

95.8+4,049%-403%

Nanoshield

4.2

n.m. (nil base)

-843%

Corporate

0.0——

Revenue by Segment

Segment (AUD K)H1 FY2025 revenueH1 FY2026 revenueH1 FY2025 profit/(loss)H1 FY2026 profit/(loss)

Semiconductor

00-347.3-2,183.6

EyeFly 3D

268.77.0-265.6-980.9

Nanoshield

12.40-117.5-53.6

Corporate

00-2,307.2-1,076.7

Total

281.17.0-3,037.6-4,294.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Group Entities

EntityJurisdictionOwnershipRole

Nanoveu Limited

Australia

Parent

Listed holding company

Nanoveu Pte Ltd

Singapore

100%

Original operating company (EyeFly3D, Nanoshield)

Fullveu Technologies (HK) Ltd

Hong Kong

51% (Fullsand 49%)

EyeFly3D commercial JV

Nanoveu EMASS Pty Ltd

Australia

100%

Holding vehicle for EMASS

Embedded A.I. Systems Pte Ltd

Singapore

100%

Semiconductor design and IP

Embedded A.I. Systems Inc

USA

100%

US sales and engineering

Spinoff Robotics Pte Ltd

Singapore

100% (from 2 Jul 2026)

Drone Division

Nanoveu Sdn Bhd

Malaysia

Dissolved in H1 FY2026

Formerly dormant

Income Statement and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (AUD K)

781.2159.5102.56.9297.6

Net loss (AUD K)

-2,320.6-2,707.3-2,159.9-2,846.4-7,601.2

Basic EPS (AUD cents)

-1.2-1.2-0.6-0.6-0.9

Diluted EPS (AUD cents)

-1.2-1.2-0.6-0.6-0.9

Dividends per share (AUD cents)

00000

Income Statement

Metric (AUD K)FY2024FY2025

Revenue

6.9297.6

Cost of sales

3.7-929.7

Gross profit

10.5-632.1

Other operating income

21.56.4

Selling and distribution

-26.3-386.9

Administration

-2,133.3-4,424.9

Research costs

-53.2-760.8

Share-based payments

-667.0-1,421.9

Operating loss

-2,847.7-7,620.3

Depreciation and amortisation

107.5173.1

EBITDA (calculated)

-2,740.2-7,447.2

Finance income

7.132.8

Finance costs

-5.7-13.7

Pre-tax loss

-2,846.4-7,601.2

Net loss

-2,846.4-7,601.2

Net loss attributable to owners

-2,809.7-7,423.3

Margin (%)

Margin (%)FY2024FY2025

Gross margin

153.2-212.4

Operating margin

-41,433-2,560.7

EBITDA margin

-39,869-2,502.6

Net margin

-41,414-2,554.3

Income Statement and Per-Share Data (Half-Yearly)

Metric (AUD K)H1 FY2025H1 FY2026

Revenue

281.17.0

Gross profit

177.07.0

Administration

-1,635.8-3,042.9

Research costs

-138.1-421.4

Share-based payments

-1,332.1-482.0

Impairment

0-41.7

Operating loss

-3,036.2-4,336.2

Net loss (total)

-3,037.6-4,294.8

Net loss attributable to owners

-2,968.8-4,158.4

Basic EPS (AUD cents)

-0.44-0.40

Balance Sheet

Metric (AUD K)FY2024FY2025

Total assets

1,321.913,554.9

Cash and equivalents

498.31,807.7

Short-term debt (interest-free loan plus current lease)

126.3198.2

Long-term debt (non-current lease)

071.9

Total debt incl. leases

126.3270.1

Net debt (negative = net cash)

-372.0-1,537.6

Total equity

338.312,093.4

Goodwill and intangibles

010,500.3

Working capital

10.31,356.5

Loan receivable (Hongtai Sheng)

258.7472.4

Contract liabilities

311.5169.2

Cash Flow

Metric (AUD K)FY2024FY2025

Operating cash flow

-1,842.5-5,845.8

Capex

0-76.5

Free cash flow

-1,842.5-5,922.3

Equity raised (net)

2,482.77,471.8

Loans advanced (Hongtai Sheng)

-258.7-213.7

Dividends paid

00

Buybacks

00

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2024FY2025

ROE (%)

—-122.3

ROA (%)

—-102.2

Current ratio (x)

1.011.98

Debt/equity (x)

0.370.02

Asset turnover (x)

—0.04

Region revenue (AUD K)

Region revenue (AUD K)FY2024FY2025

Asia

6.9297.6

North America

00

Australia

00

Total

6.9297.6

Region non-current assets (AUD K)

Region non-current assets (AUD K)FY2024FY2025

Asia

328.010,670.2

Australia

0138.6

North America

00

Per-Share Data

MetricFY2019FY2020FY2021FY2022FY2023FY2024FY2025

Year-end share price (AUD cents)

5.26.53.20.92.33.48.4

Share Price & Returns

WindowReference priceChange (calculated)

YTD 2026 (vs 31 Dec 2025)

8.4c

-31%

~3-year (vs 31 Dec 2023)

2.3c

+152%

~5-year (vs 31 Dec 2021)

3.2c

+81%

Since IPO (Nov 2018)

20.0c

-71%

Valuation Snapshot

MultipleValueBasis

Market cap

~A$63.1M

A$0.058 × ~1.087bn shares (StockWire X shows A$58.7M on 22 Sep 2026)

Enterprise value

~A$58.7M

Market cap minus A$5.14M cash plus A$0.72M debt and leases (30 Jun 2026; cash has since fallen)

EV/Sales (TTM revenue A$23.4K)

~2,500x

TTM = FY2025 − H1 FY2025 + H1 FY2026

P/B

~4.1x

Equity A$15.52M

P/tangible book

~12.6x

Tangible equity ~A$5.0M

Analyst Conclusions

Management guidance

No quantitative guidance is given. Qualitative priorities:

  • Publish measured 16nm power and performance data.

  • Supply engineering samples and evaluation boards to selected customers.

  • Start the 22nm full-mask tape-out in H2 2026.

  • Convert 22nm evaluations into design-ins.

  • Commercialise the ALICE and METRON drone platforms.

  • Deliver the India EyeFly3D pilot by Q4 2026.

  • Progress Nanoshield CSP licensing.

Consensus growth expectations

None. There is no broker coverage.

Bull case

  1. Silicon is real, at two nodes. Few ASX microcaps have taken two designs through TSMC. Strong 16nm characterisation data, especially if it independently confirms the claimed efficiency lead, could open tier-one design-ins and justify a re-rating toward peers that already earn chip revenue.

  2. Funding overhang is self-correcting near the current price. About 162M in-the-money options (A$0.045–A$0.05, expiring Dec 2026 to May 2027) could bring in about A$7.8M if exercised. That would roughly double the 30 June 2026 cash with no new placement discount.

  3. Drone and defence optionality. Measured 48.5% cruise-efficiency gains, owned airframes and GPS-free swarm IP fit current defence-drone procurement themes. These are higher-value, faster-procurement niches than consumer wearables.

Bear case

  1. Revenue is going backwards. Revenue was A$7K in H1 FY2026, and FY2025's A$298K came from one-off EyeFly3D shipments. Eighteen months after the EMASS deal, no chip revenue has been booked, while burn has doubled to about A$7.9M a year.

  2. Dilution is structural. There are about 1.49bn fully diluted shares. Runway was about 7–8 months at 30 June 2026. The strategy now spans four verticals. Further equity raisings are likely, and each one dilutes per-share value before commercial proof arrives.

  3. Governance and disclosure quality are below institutional standard. One independent director, an executive chair, no remuneration committee, an auditor change, repeated internal inconsistencies in the filings, an unsecured interest-free loan to a third party, and a large university donation together raise the cost of capital.

Key catalysts and monitorables (next 12 months)

  • Published 16nm silicon characterisation data: power per inference, wake latency and BLE RF performance.

  • First announced design-win or binding production purchase order for ECS-DoT. A$1M of cumulative revenue triggers the EMASS Class C rights.

  • Start and completion of the 22nm full-mask tape-out.

  • Sept-quarter 2026 Appendix 4C (late Oct 2026): cash balance and burn.

  • Exercise of the 93.4M A$0.05 options before 31 Dec 2026.

  • Repayment status of the Hongtai Sheng loan.

  • India EyeFly3D shipment by Q4 2026 and follow-on orders toward the 1M-unit exclusivity threshold.

  • First Drone Division revenue or defence engagements; NTU licence conversion decision.

  • FY2026 impairment test of the A$10.5M EMASS intangible (Feb 2027 accounts, Stantons' first full-year audit).

  • Board refresh to add independent directors.

Analyst verdict

Nanoveu is now a different company from the one that listed in 2018. The EyeFly3D and Nanoshield businesses, which never produced more than about A$0.8M in a year, have become secondary. The company is now an edge-AI fabless chip developer that is also building a drone business. The technical progress since the March 2025 EMASS acquisition is real and, for a company of this size, unusually fast. It took the 16nm design from architecture to GDS sign-off in about six months, completed a TSMC tape-out in January 2026, and received engineering samples in September 2026. Live drone trials showed a 48.5% average cruise-efficiency gain at under 10mW, and the company has signed reference-design collaborations with Bosch Sensortec, Semtech and Arrow. These are meaningful signals that the architecture works.

The financial picture is the reverse. Revenue fell 98% to A$7K in H1 FY2026. Operating burn doubled to A$3.9M per half. Cash of A$5.1M at 30 June 2026 implies a funding event or large option exercises by early 2027. About 59% of the balance sheet is an acquired intangible valued at the share price paid for it. Governance (one independent director out of five, an executive chair, no remuneration committee) and recurring inconsistencies in the filings fall short of what generalist institutions expect.

At roughly A$60M market capitalisation, the market is valuing ECS-DoT optionality and assigning little value to the legacy divisions. That price is reasonable only if the 16nm characterisation confirms a clear power-efficiency lead and leads to a disclosed design-win within the next two to three quarters. Without a design-win, the company returns to repeated placements at discounts. The stock is speculative and binary, so position size should be set accordingly. The next three checkpoints are the published 16nm silicon data, any binding production order, and the cash balance in the Sept-quarter and Dec-quarter 2026 Appendix 4Cs.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointedBackground / educationIndependent?

Dr David Pevcic

Executive Chairman

Director 3 Feb 2023; Executive Chair Oct 2024

Investor in resources and technology. Chairs Infini Resources (ASX: I88) and Battery Age Minerals (ASX: BM8). BSc, MBBS, University of Western Australia.

No (executive)

Alfred Chong

Managing Director and CEO; Founder

14 Feb 2018

Former Asia-Pacific CEO of Atex Media Command; CEO of THISS Technologies and 121View; CMO of 3D International. BSc Computer Science and MBA, University of San Francisco.

No (executive)

Steven Apedaile

Non-Executive Director

14 May 2018

30+ years in accounting (KPMG Hong Kong, Horwath Hong Kong). Executive Chairman of Sprintex (ASX: SIX). FCA, MAICD.

Yes

Prof. Mohamed M. Sabry Aly

Non-Executive Director; EMASS Founder and CTO

1 Dec 2025

Founded EMASS while an Associate Professor at NTU. Former Stanford postdoctoral researcher. Task Force Lead for Singapore EDB's Future of Microelectronics initiative. More than 100 publications; part of DARPA's 3DSoC program. PhD.

No (founder, ~9.5% holder)

Siyuan (Raymond) Chen

Executive Director and CFO

CFO 4 Feb 2025; Director 1 Dec 2025

Previously at Iluka Resources, NRW Holdings and Equinox Resources; began at KPMG audit. MBA, Cambridge Judge. Engaged through Oxbridge Advisory Pty Ltd.

No (executive)

Executive Leadership Team

NameRoleAppointedBackground

Mark Goranson

CEO, Semiconductor Technologies division (EMASS)

Jan 2025

40+ years in semiconductors; senior roles at Intel, ON Semiconductor and TE Connectivity

Dr Chee How Tan

Head of Drone Division

2 Jul 2026

Co-founder of Spinoff Robotics; 4+ years as a research fellow at SUTD in lean sensing and embodied perception for aerial robotics

Harry Spindler

Company Secretary

4 Feb 2025

23 years in governance and capital markets; CA ANZ, FINSIA

Directors' Remuneration

NameSalary and feesNon-monetarySuper/CPFShare-basedTotalPerformance-related (%)

Alfred Chong

293,1589,47812,951105,561421,14825

Dr David Pevcic

122,8835,8010842,340971,02487

Raymond Chen

114,00024200114,2420

Steven Apedaile

56,2205,80104,05766,0786

Dr Michael Winlo (to 1 Dec 2025)

36,3085,3185,16032,61079,39641

Prof. Mohamed Sabry Aly (from 1 Dec 2025)

27,74824203,68931,67912

Total KMP

650,317

26,882

18,111

988,257

1,683,567

59

KMP remuneration total (AUD K)

FY2024

FY2025

————

Total KMP remuneration

616.71,683.6————

Of which share-based payments

151.2988.3————

Major Shareholders

HolderSharesApprox. % of ~1.087bnAdditional securitiesSource

Prof. Mohamed Sabry Aly

102,936,3529.5

49,752,570 EMASS performance rights plus 5,000,000 VWAP rights

FY2025 Annual Report

Dr David Pevcic (direct and indirect)

~59,355,337

5.5

17,990,075 options; 5,000,000 rights

Annual Report plus Appendix 3Y (26 Jun 2026)

Alfred Chong

48,416,0204.5

5,700,000 rights

Annual Report

Steven Apedaile

4,540,3500.4

5,030,000 rights

Annual Report

Raymond Chen

~402,982

0.04

80,645 options plus placement options

Annual Report plus Appendix 3Y

Board total

~215.7M

~19.8

—

Calculated

Governance Detail

SecurityNumber

Options

270,576,171

Performance rights (at 30 Jun 2026)

125,833,333

Spinoff performance rights

4,000,000

ESIP performance rights (Jul 2026)

6,000,000

Approximate fully diluted share count

~1.49bn

Competitive Landscape

Competitors by Segment

SegmentCompetitorTypeNotes

Ultra-low-power edge-AI SoC

Ambiq Micro (NYSE: AMBQ)

Public, US

Apollo/Atomic families; FY2025 net sales US$72.5M; management sees a path to more than US$100M

Ultra-low-power edge-AI SoC / IP

BrainChip (ASX: BRN)

Public, ASX

Akida neuromorphic IP and AKD1500 silicon; FY2025 revenue US$1.89M; net loss US$20.47M

Edge-AI MCU / NPU

STMicroelectronics (STM32N6 and others)

Public, large-cap

Also a partner (sensing)

Edge-AI MCU

Analog Devices (MAX78000 family)

Public, large-cap

CNN accelerator MCU

Edge-AI MCU

NXP Semiconductors

Public, large-cap

i.MX RT / MCX with NPU

Edge-AI MCU

Infineon

Public, large-cap

PSoC Edge

Always-on audio AI

Syntiant

Private

Neural decision processors

Ultra-low-power processors

GreenWaves Technologies

Private

GAP RISC-V processors

Neuromorphic

Innatera

Private

Spiking neural processors

Edge-AI silicon (higher power)

Hailo

Private

Vision accelerators

Glasses-free 3D

Leia Inc.; Dimenco

Private

Lightfield / 3D display tech

Tethered drones

Elistair; Hoverfly

Private

Tethered UAS for persistent surveillance

Solar anti-soiling coatings

Various nanocoating vendors

Mixed

Fragmented

Peer Comparison FY2025

MetricNanoveu (FY2025, AUD)Ambiq (FY2025, USD)BrainChip (FY2025, USD)

Revenue

A$0.30M

US$72.5M

US$1.89M

Revenue growth

+4,230% (from A$6.9K)

—+374%

Gross margin

-212%

Q1 FY2026 non-GAAP guidance 44–45%

—

Net margin

-2,554%—

About -1,083% (calculated)

R&D intensity

Research costs 256% of revenue (understated)

Q4 FY2025 non-GAAP R&D US$9.3M (~45% of Q4 sales)

—

Recent Developments

--

Company Snapshot

$0.2M

Revenue

24

Employees

2001

Founded

Perth, Australia

Headquarters

SWOT Analysis

Strengths

  • Silicon at two nodes. Two TSMC tape-outs (22nm and 16nm). 16nm engineering samples were received about eight months after the January 2026 tape-out (StockWire X, 22 Sep 2026).
  • Measured efficiency. Live drone trials showed a 48.5% average cruise-efficiency gain at 7 m/s with ECS-DoT drawing under 10mW (13 Jul 2026). Simultaneous keyword spotting and voice ID ran at 400–500 µW.
  • Tier-1 ecosystem. Collaborations with Bosch Sensortec (Jul 2026), Semtech and Arrow (2025).
  • Third-party recognition. CES 2026 Best in Show for AI/ML.
  • Aligned founders. Board holds about 20% of shares; the EMASS founder holds about 9.5% plus 49.8M milestone rights linked to revenue and technology.
  • Clean leverage. No interest-bearing debt. Total debt including leases was A$0.7M against A$5.1M cash at 30 Jun 2026.
  • Protected IP. Exclusive licence of US Patent 12,651,452 B2; drone flight-control patents lodged; NTU swarm IP.

Weaknesses

  • Negligible revenue. H1 FY2026 revenue was A$6,954, down 98%. There is still no semiconductor revenue 18 months after the acquisition.
  • Accelerating burn. Operating cash outflow was A$3.93M in H1 FY2026, double H1 FY2025, giving about 7–8 months of runway from 30 June 2026.
  • Governance. One independent director out of five; no remuneration committee in FY2025; executive chair.
  • Negative gross margin. FY2025 cost of sales (A$929.7K) was more than three times revenue.
  • Too many priorities. Four businesses (chips, drones, 3D films, coatings) on a roughly A$8M a year cost base.
  • Filing quality. Several internal inconsistencies: D&A (A$173K vs A$32.6K), working capital, the FY2024 non-current asset total, the chair's appointment date, and the JV percentage (41% vs 49%) in the July 2024 release.

Opportunities

  • Design-ins. 16nm characterisation results and evaluation boards for selected customers (next 3–6 months) could turn the growing 22nm evaluation pipeline into design-wins.
  • Defence drones. ALICE tethered drone plus GPS-free navigation IP could address defence and security buyers.
  • India EyeFly3D scale-up. Exclusivity requires 1M units within 18 months. Converting the US$300K pilot would be the first material recurring revenue.
  • China distribution for the 22nm chip (Q2 2026 appointment).
  • Option-exercise funding. 93.4M options at A$0.05 expiring 31 Dec 2026 are in the money at A$0.058 (about A$4.7M).
  • Integrated BLE on 16nm lowers customer BOM cost for wearables and tags.

Threats

  • Incumbent NPU-MCUs from ST, NXP, ADI and Infineon bundle AI into existing customer relationships.
  • Better-funded specialists: Ambiq (US$72.5M revenue, public-market capital) and BrainChip (A$37M raise).
  • Dilution: about 1.49bn fully diluted shares; further raisings likely before cash-flow breakeven.
  • Impairment risk: the A$10.5M EMASS intangible is about 59% of total assets and depends on commercialisation forecasts.
  • Credit exposure: the Hongtai Sheng loan (A$452K, matured 31 Jul 2026) is unsecured and interest-free; repayment is not confirmed.
  • Foundry, geopolitical and export-control exposure: TSMC dependency, a China distributor, and drone/defence end-markets.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
3 Apr 2025EMASS–CND strategic collaborationEarly ecosystem building
10 Apr 2025US semiconductor team expandedGo-to-market in the largest OEM market
30 May 2025AGM; ESIP approvedEquity incentive framework
7 Aug 2025Pevcic subscribes A$400K at A$0.031 (12.9M shares)Insider support at lows
Aug 2025~A$2.3M placement, with chairman participation (TipRanks)Funding for EMASS, EyeFly3D and Nanoshield
29 Aug 2025H1 FY2025 resultsFirst period including EMASS
7 Oct 2025Live drone testing program announcedMoves from simulation to real-world validation
31 Oct 2025Sept-quarter report: Phase 2 simulations ~60% average flight-time gain; 16nm at synthesis; patents lodgedTechnical validation
Q4 2025Arrow Electronics and Semtech collaborationsDistribution and IoT reference designs
1 Dec 2025Sabry Aly and Chen appointed directors; Winlo resignsIndependence falls to 1 of 5
17 Dec 202516nm final GDS; ~6 months from architecture to GDS per companyExecution speed
Jan 2026CES 2026 Best in Show awardThird-party recognition
16–20 Jan 2026Trading halt; A$7.5M placement at A$0.088Largest raise to date; ~8% dilution
27 Jan 202616nm tape-out at TSMC; tranche 1 (A$7.38M) settlesSilicon moves into fabrication
28 Jan 2026Dec-quarter Appendix 4C—
17 Feb 2026NTU drone-swarm IP exclusive evaluation licenceDrone autonomy IP
27 Feb 2026FY2025 results: revenue A$298K (+4,230%), loss A$7.6M (+167%)Burn rising sharply
5 Mar 2026Bone-conduction keyword-spotting hearables reference designHearables vertical
25 Mar 2026Pitt Street Research Semiconductor Conference presentationInvestor outreach
2 Apr 2026BDO resigns; Stantons appointed auditorGovernance monitorable
30 Apr 2026March-quarter Appendix 4C—
11–15 May 2026Trading halt and suspension; Spinoff Robotics agreement; reinstatementDrone vertical integration
29 May 2026AGM; directors' A$120K placement approved—
9 Jun 2026Investor webinarRoadmap disclosure
16 Jun 2026Microphone-free keyword spotting below 1mWAlways-on voice
22 Jun 2026First live drone flights: 27.2% average cruise-efficiency gainReal-world validation (smaller than the ~60% simulation)
25 Jun 2026AI voice fusion (keyword spotting plus voice ID at the same time)Multimodal co-processor positioning
26 Jun 2026Placement tranche 2 (A$120K, directors) settlesInsider buying at A$0.088
2 Jul 2026Spinoff acquisition completes; 6M ESIP rights and 2.5M incentive shares issuedDrone Division formed
9–13 Jul 2026Trading halt; Phase 2 drone results: 48.5% average at 7 m/sStock rose from ~A$0.044 to ~A$0.067 in late July
22 Jul 2026June-quarter Appendix 4C—
23 Jul 2026Bosch Sensortec asset-tracking reference designTier-1 sensor partner
11 Aug 2026One Immersive India OEM deal; US$300K pilot purchase order (US$165K received)EyeFly3D revenue in Q4 2026
24 Aug 2026H1 FY2026 results: revenue A$7K (-98%), loss A$4.16M (+40%), cash A$5.14MCash runway focus
1 Sep 2026Exclusive licence of US Patent 12,651,452 B2IP protection for 16nm OD accelerator
~21–22 Sep 2026First 16nm engineering samples from TSMC; bring-up and characterisation beginKey technical de-risking milestone

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Income Statement: Revenue & Gross Profit (FY2024–FY2025): Cost of sales fell from AUD 0 Mn in FY2024 to AUD -0.9 Mn in FY2025.
Nanoveu Limited — Income Statement: Revenue & Gross Profit (FY2024–FY2025)
Series (AUD Mn)FY2024FY2025
Cost of sales0-0.9
Gross profit0-0.6

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Nanoveu Limited, Appendix 4E and Annual Financial Report for the year ended 31 December 2025 (ASX, 27 Feb 2026) (announcements.asx.com.au)
  2. Nanoveu Limited, Appendix 4D and Interim Financial Report for the half-year ended 30 June 2026 (24 Aug 2026) (bulletin.webull.com)
  3. Nanoveu, Capital Raise Completion and Cleansing Statement (27 Jan 2026) (announcements.asx.com.au)
  4. Nanoveu, Change of Auditor (2 Apr 2026) (bulletin.webull.com)
  5. Nanoveu, Completion of Spinoff Robotics acquisition (2 Jul 2026) (bulletin.webull.com)
  6. Nanoveu, June 2026 Quarterly Activities Report (22 Jul 2026) (bulletin.webull.com)
  7. Nanoveu, Sept 2025 Quarterly (31 Oct 2025) (wcsecure.weblink.com.au)
  8. Nanoveu, Spinoff Robotics acquisition announcement (wcsecure.weblink.com.au)
  9. Nanoveu, EyeFly3D JV (30 Jul 2024) (announcements.asx.com.au)
  10. Nanoveu, Rahum Nano Tech purchase order (21 Oct 2024) (announcements.asx.com.au)
  11. SUTD media release on the Spinoff Robotics acquisition (sutd.edu.sg)
  12. StockWire X, 16nm engineering samples (22 Sep 2026) (stockwirex.com)
  13. InvestSMART NVU announcements and price data (investsmart.com.au)
  14. FilingReader, H1 FY2026 results summary (filingreader.com)
  15. TipRanks, NVU revenue history (FY2016–FY2024, aggregator) (tipranks.com)
  16. TipRanks, NVU overview (tipranks.com)
  17. Investing.com, NVU quote (24 Sep 2026) (il.investing.com)
  18. Market Index, NVU profile (marketindex.com.au)
  19. FinancialFilings.com, NVU identifiers (financialfilings.com)
  20. Dealroom, Nanoveu profile (app.dealroom.co)
  21. Gordon Capital, IPO research report (2018) (onmarket.com.au)
  22. Pearler, NVU profile (pearler.com)
  23. Ambiq Micro, FY2025 results (8-K, Mar 2026) (sec.gov)
  24. Ambiq Q4 FY2025 earnings call coverage (finance.yahoo.com)
  25. BrainChip FY2025 results coverage (smallcaps.com.au)
  26. CompaniesMarketCap, BrainChip (companiesmarketcap.com)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.